"Amyloid beta-Peptides" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Peptides generated from AMYLOID BETA-PEPTIDES PRECURSOR. An amyloid fibrillar form of these peptides is the major component of amyloid plaques found in individuals with Alzheimer's disease and in aged individuals with trisomy 21 (DOWN SYNDROME). The peptide is found predominantly in the nervous system, but there have been reports of its presence in non-neural tissue.
| Descriptor ID |
D016229
|
| MeSH Number(s) |
D12.644.024 D12.776.049.407.249.500 D12.776.543.039.500
|
| Concept/Terms |
Amyloid beta-Peptides- Amyloid beta-Peptides
- Amyloid beta Peptides
- beta-Peptides, Amyloid
- Alzheimer's ABP
- ABP, Alzheimer's
- Alzheimer ABP
- Alzheimers ABP
- Alzheimer's Amyloid Fibril Protein
- Amyloid AD-AP
- AD-AP, Amyloid
- Amyloid AD AP
- beta-Amyloid Protein
- Protein, beta-Amyloid
- beta Amyloid Protein
- Amyloid beta-Protein
- Amyloid beta Protein
- beta-Protein, Amyloid
- Amyloid beta-Proteins
- Amyloid beta Proteins
- beta-Proteins, Amyloid
- Amyloid Fibril Protein, Alzheimer's
- Amyloid Protein A4
- Protein A4, Amyloid
- Alzheimer beta-Protein
- Alzheimer beta Protein
- beta-Protein, Alzheimer
- Amyloid beta-Peptide
- Amyloid beta Peptide
- beta-Peptide, Amyloid
|
Below are MeSH descriptors whose meaning is more general than "Amyloid beta-Peptides".
Below are MeSH descriptors whose meaning is more specific than "Amyloid beta-Peptides".
This graph shows the total number of publications written about "Amyloid beta-Peptides" by people in this website by year, and whether "Amyloid beta-Peptides" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1992 | 1 | 0 | 1 |
| 1998 | 1 | 0 | 1 |
| 1999 | 1 | 0 | 1 |
| 2000 | 1 | 1 | 2 |
| 2001 | 0 | 1 | 1 |
| 2002 | 2 | 1 | 3 |
| 2003 | 7 | 2 | 9 |
| 2004 | 2 | 0 | 2 |
| 2005 | 5 | 1 | 6 |
| 2006 | 3 | 3 | 6 |
| 2007 | 2 | 5 | 7 |
| 2008 | 0 | 2 | 2 |
| 2009 | 4 | 5 | 9 |
| 2010 | 4 | 5 | 9 |
| 2011 | 8 | 4 | 12 |
| 2012 | 5 | 1 | 6 |
| 2013 | 3 | 8 | 11 |
| 2014 | 5 | 5 | 10 |
| 2015 | 3 | 2 | 5 |
| 2016 | 2 | 3 | 5 |
| 2017 | 5 | 4 | 9 |
| 2018 | 8 | 3 | 11 |
| 2019 | 6 | 4 | 10 |
| 2020 | 2 | 4 | 6 |
| 2021 | 6 | 10 | 16 |
| 2022 | 0 | 4 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Amyloid beta-Peptides" by people in Profiles.
-
Neuronal Rubicon Represses Extracellular APP/Amyloid ß Deposition in Alzheimer's Disease. Cells. 2022 06 07; 11(12).
-
Concerted type I interferon signaling in microglia and neural cells promotes memory impairment associated with amyloid ß plaques. Immunity. 2022 05 10; 55(5):879-894.e6.
-
The clock modulator Nobiletin mitigates astrogliosis-associated neuroinflammation and disease hallmarks in an Alzheimer's disease model. FASEB J. 2022 03; 36(3):e22186.
-
Therapeutic Targets for Alzheimer's Disease: Amyloid Vs. Non-Amyloid. Where Does Consensus Lie Today? An CTAD Task Force Report. J Prev Alzheimers Dis. 2022; 9(2):231-235.
-
Apolipoprotein E Proteinopathy Is a Major Dementia-Associated Pathologic Biomarker in Individuals with or without the APOE Epsilon 4 Allele. Am J Pathol. 2022 03; 192(3):564-578.
-
Combinatorial model of amyloid ß and tau reveals synergy between amyloid deposits and tangle formation. Neuropathol Appl Neurobiol. 2022 02; 48(2):e12779.
-
Restoring activity in the thalamic reticular nucleus improves sleep architecture and reduces Aß accumulation in mice. Sci Transl Med. 2021 11 03; 13(618):eabh4284.
-
Recent insights into the role of glia and oxidative stress in Alzheimer's disease gained from Drosophila. Curr Opin Neurobiol. 2022 02; 72:32-38.
-
Innate immunity stimulation via CpG oligodeoxynucleotides ameliorates Alzheimer's disease pathology in aged squirrel monkeys. Brain. 2021 08 17; 144(7):2146-2165.
-
Age-related cognitive impairment is associated with low serum concentrations of testosterone and CSF levels of amyloid beta 42 in male cynomolgus monkeys (Macaca fascicularis). J Med Primatol. 2021 10; 50(5):270-272.